Abstract Library

#1648 Treatment Patterns and Survival Among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours in Sweden – A Population-Based Register-Linkage and Medical Chart Review Study

Introduction: Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) is a group of neoplasms derived from the endocrine system in the GI tract and pancreas.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Johanson V

Authors: Lesén E, Granfeldt D, Houchard A, Berthon A, Dinet J,

Keywords: GEP-NET, SSA, treatment patterns, survival,

#209 A Randomized, Cross-Over Study in Patients with Neuroendocrine Tumors (NETs) to Assess Patient Preference of Lanreotide Autogel Given by Either Self/Partner or Healthcare Professional

Introduction: Ready-to-use Lanreotide Autogel provides the option of self/partner administration for patients with NET. This is anticipated to reduce treatment cost and negative impact on daily life.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Johanson V, Wilson B, Abrahamsson A, Jianu C, Calissendorff J,

Keywords: neuroendocrine tumors, NET, self-administration, somatostatin analogs, lanreotide,